abstract |
Novel hetarylaminonaphthyridine derivatives of formula (I) n nwherein X, R1, R2, R3, R4, W1, W2, W3, W5 and W6 have the meaning according to claim 1 , are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors. |